Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery

Purpose The aim of this study was to define a threshold of minimal clinically important improvement (MCII) for interpreting patient condition following video-assisted thoracoscopic surgery (VATS). Methods Patients undergoing VATS were recruited for this multicenter, prospective, observational cohort...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2022-09, Vol.29 (9), p.5593-5604
Hauptverfasser: Xu, Wei, Dai, Wei, Gao, Zhen, Wang, Xin Shelley, Tang, Li, Pu, Yang, Yu, Qingsong, Yu, Hongfan, Nie, Yuxian, Zhuang, Weitao, Qiao, Guibin, Cleeland, Charles S., Shi, Qiuling
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose The aim of this study was to define a threshold of minimal clinically important improvement (MCII) for interpreting patient condition following video-assisted thoracoscopic surgery (VATS). Methods Patients undergoing VATS were recruited for this multicenter, prospective, observational cohort study. Symptoms were measured using the MD Anderson Symptom Inventory–Lung Cancer Module perioperatively. To define MCIIs, we first identified index symptoms, defined as the most severe symptoms showing the largest reduction from day 1 post-surgery to discharge. MCIIs for each index symptom were then obtained via an anchor-based approach. Symptom recovery was defined as an MCII after post-surgery day 1. Cox regression models were used to identify risk factors for unrecovered index symptoms. Results Using 366 patients, we identified pain and fatigue as index symptoms after VATS. MCII was defined as a 30% reduction in pain or fatigue. At discharge, 22.6% of patients had not recovered from pain and 22.4% had not recovered from fatigue. Cox models found that risk factors for unrecovered pain were Charlson Comorbidity Index score ≥1 (hazard ratio [HR] 1.36, 95% confidence interval [CI] 1.04–1.77; p  = 0.02) and preoperative neoadjuvant therapy (HR 2.78, 95% CI 1.13–6.83; p  = 0.02). Malignancy was a risk factor for unrecovered fatigue (HR 1.47, 95% CI 1.02–2.13; p  = 0.04). Conclusion Pain and fatigue can be used as index measures for symptom recovery in patients following VATS. A 30% MCII represented meaningful recovery after VATS and could identify patients who may need extensive care after discharge.
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-022-11629-7